Surreal illustration of a Bactrian camel scientist with esophageal silhouette.

Camel Milk: The Unexpected Weapon Against Esophageal Cancer?

Lena Kashyap monogram
Lena Kashyap in Health & Wellness October 2026 • 4 min read.

"New research explores how a unique fraction of camel milk could revolutionize esophageal cancer treatment."


Esophageal cancer remains a significant global health challenge, ranking as the eighth most common malignancy and the sixth leading cause of cancer-related deaths worldwide. Despite advancements in treatment, the overall five-year survival rate for patients remains discouragingly low, highlighting the urgent need for innovative therapeutic strategies.

In a groundbreaking study, researchers have turned to an unconventional source: camel milk. Specifically, they've investigated the potential of an active fraction extracted from Xinjiang Bactrian camel whey, dubbed TR35, to combat human esophageal cancer cells. This research explores TR35's effects both in laboratory settings (in vitro) and in living organisms (in vivo), offering new insights into its anti-cancer mechanisms.

The study, recently published in Clinical Nutrition, details how TR35 inhibits the proliferation of esophageal cancer cells and induces apoptosis, or programmed cell death. By employing transcriptomics and proteomics analyses, scientists have begun to unravel the molecular pathways through which TR35 exerts its beneficial effects, paving the way for potential therapeutic applications.

AI Search Multiple angles on this topic

Esophageal Cancer by the Numbers

Esophageal cancer remains a significant global health concern, with detailed statistics tracked by organizations like the National Cancer Institute's SEER program. Recent research has identified TR35, an active fraction isolated from Xinjiang Bactrian camel milk, as a promising compound with anti-cancer properties. Studies have demonstrated that TR35 can significantly inhibit the proliferation of Eca-109 esophageal cancer cells in both in vitro and in vivo models, suggesting a potential natural therapeutic approach.

Conventional Treatments and Emerging Natural Alternatives

The standard approach to treating esophageal cancer typically involves conventional therapies such as chemotherapy, radiation, and surgery. However, researchers are exploring natural alternatives due to limitations and side effects associated with standard treatments. The study of TR35 from Xinjiang Bactrian camel milk represents an effort to investigate antitumor active fractions that could offer new therapeutic options with potentially fewer adverse effects.

Traditional Medicine Meets Modern Science

Camel milk has been consumed for centuries in various cultures and is often believed to possess medicinal qualities. The recognition of its potential anti-cancer properties represents a convergence of traditional knowledge and modern scientific investigation. While historical use provides a foundation for current research, rigorous scientific studies are needed to validate these traditional claims and establish evidence-based applications.

TR35: A Natural Anti-Cancer Agent?

Surreal illustration of a Bactrian camel scientist with esophageal silhouette.

The study's core findings revolve around TR35, an active fraction isolated from Xinjiang Bactrian camel milk. This compound demonstrated a remarkable ability to inhibit the proliferation of Eca109 esophageal cancer cells and trigger apoptosis, a process crucial for eliminating cancerous cells. These effects were observed through various assays, including MTT assays, Annexin V-FITC Apoptosis Detection, and caspase-3 activity measurements.

Further bolstering these findings, in vivo experiments showed that TR35 effectively suppressed the growth of xenografted tumors in nude mice without causing any significant loss in body weight. This is a critical observation, as many conventional cancer treatments are associated with debilitating side effects. The fact that TR35 exhibited anti-tumor activity without compromising the overall health of the mice underscores its potential as a therapeutic agent.

To understand how TR35 works, the researchers employed advanced analytical techniques:
  • RNA-Seq Analysis: This technique allowed them to identify genes that were differentially expressed in TR35-treated Eca109 cells compared to untreated cells.
  • 2-DE Combined with Mass Spectrometry: This proteomic approach enabled the identification of proteins that showed altered expression levels in response to TR35 treatment.
These analyses revealed a total of 405 differentially expressed genes and 55 differentially expressed proteins in TR35-treated Eca109 cells, providing a comprehensive molecular snapshot of its effects.
AI Search Multiple angles on this topic

Recent Advances in Camel Milk Research

Current research continues to explore the therapeutic potential of camel milk and its components. Scientists are investigating various bioactive compounds within camel milk that may contribute to its health benefits. These studies represent the ongoing effort to understand the mechanisms behind camel milk's potential medicinal properties and its applications in modern healthcare.

Challenges and Limitations in Current Research

Despite promising preliminary findings, research on camel milk's anti-cancer properties faces several challenges. The specificity of TR35's effects on esophageal cancer cells requires further investigation to understand its mechanisms of action completely. Additionally, translating in vitro and in vivo findings to human clinical applications remains a significant hurdle that researchers must address.

Camel Milk vs. Conventional Cancer Therapies

Scientists have discovered that TR35, a special fraction in Xinjiang Bactrian camel milk, shows promising anti-cancer effects, particularly against esophageal cancer. This breakthrough opens doors for new, natural cancer therapies that could complement or potentially offer alternatives to conventional treatments. The natural origin of camel milk components may present advantages in terms of accessibility and cultural acceptance in certain regions.

These results might implicate that downregulation of specific proteins identified in this study may be the cause of this tumor growth inhibition. This study sheds light on the potential therapeutic advantages based on the historical anti-cancer activities of camel milk.

Future Implications

The findings from this study open up exciting avenues for further research and potential therapeutic development. While the results are promising, it's important to acknowledge that this is an early-stage study, and more research is needed to fully understand the mechanisms of action of TR35 and its potential for clinical application. Clinical trials will be necessary to confirm the safety and efficacy of TR35 in human patients with esophageal cancer. However, this study provides a compelling rationale for exploring camel milk as a source of novel anti-cancer agents.

AI Search Multiple angles on this topic

Integrating Findings into Clinical Understanding

The research on TR35 from Xinjiang Bactrian camel milk demonstrates significant potential in inhibiting esophageal cancer cell proliferation. Researchers have successfully isolated this antitumor active fraction and evaluated its effects using both laboratory and animal models. These findings suggest that camel milk components could contribute to developing new therapeutic strategies for esophageal cancer treatment.

Expanding Research Horizons

The multifaceted therapeutic properties of camel milk extend beyond anti-cancer potential, with research showing benefits for cardiovascular health and overall metabolic wellness. Future research directions include exploring camel milk's applications across various health conditions and advancing clinical applications. The JAMA Network continues to publish the latest advances in esophageal cancer research, including epidemiology, diagnosis, management, and prevention strategies.

Implementation and Accessibility Considerations

While research on camel milk's therapeutic properties shows promise, several systemic challenges remain. Standardization of active compounds, quality control, and sustainable sourcing present practical implementation hurdles. Additionally, integrating traditional remedies into modern healthcare systems requires careful consideration of regulatory frameworks and evidence-based medicine standards.

Implications for Cancer Prevention and Treatment

Research has observed an association between dairy products, especially fermented ones, and a lower risk of esophageal and stomach cancers. This suggests that dietary factors may play a role in cancer prevention strategies. The study of camel milk's anti-cancer mechanisms sheds light on potential therapeutic advantages based on historical use, offering new perspectives for patient care and dietary recommendations.

What the cell comparisons show-and do not show

The gene and protein differences show that TR35-treated cells had a changed molecular profile relative to untreated cells. Those changes identify differences associated with treatment, but by themselves do not establish which changes caused an anti-cancer effect.[1]

How the evidence compares across cancer models

A later account of TR35 described its earlier reported inhibitory effects against esophageal cancer, while noting that its effects against lung cancer were unclear. This places the available account within a cancer-specific line of investigation rather than establishing a shared effect across cancers.[2]

A review says camel milk’s clinical effectiveness and value as a therapeutic agent remain unclear, and cautions that camel milk should not replace standard therapies for human indications. This broader assessment limits how far findings from experimental models can be translated into claims about treatment.[3]

What remains unresolved about camel milk evidence

  • Which of the molecular differences in treated Eca109 cells, if any, are responsible for the observed effects, rather than accompanying them?[1]
  • What would animal and clinical evidence show about the efficacy of camel milk’s bioactive molecules?[4]

Sources

  1. Transcriptomics and proteomics analyses of anti-cancer mechanisms of TR35-An active fraction from Xinjiang Bactrian camel milk in esophageal carcinoma cell. (pubmed.ncbi.nlm.nih.gov)
  2. TR35 Exerts Anti-tumor Effects by Modulating Mitogen-Activated Protein Kinase and STAT3 Signaling in Lung Cancer Cells (pmc.ncbi.nlm.nih.gov)
  3. The Therapeutic Effects of Camel Milk: A Systematic Review of Animal and Human Trials. (pubmed.ncbi.nlm.nih.gov)
  4. Prospective Role of Bioactive Molecules and Exosomes in the Therapeutic Potential of Camel Milk against Human Diseases: An Updated Perspective (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What is TR35, and how is it linked to combating esophageal cancer?

TR35 is an active fraction extracted from Xinjiang Bactrian camel milk. Research indicates that TR35 has shown promise in fighting esophageal cancer cells. In laboratory studies (in vitro) and in living organisms (in vivo), TR35 inhibits the proliferation of esophageal cancer cells and induces apoptosis, or programmed cell death, demonstrating its potential as an anti-cancer agent. Further research is being done to understand the mechanisms of action of TR35 and its potential for clinical application.

2

How does TR35 work at a cellular level to fight esophageal cancer?

TR35 works by inhibiting the proliferation of Eca109 esophageal cancer cells and triggering apoptosis. Researchers used various assays, including MTT assays, Annexin V-FITC Apoptosis Detection, and caspase-3 activity measurements, to demonstrate these effects. Furthermore, advanced analytical techniques, such as RNA-Seq Analysis and 2-DE combined with Mass Spectrometry, were employed to identify differentially expressed genes and proteins in TR35-treated cells, providing a molecular snapshot of its effects and revealing the pathways through which TR35 exerts its beneficial effects.

3

What are the key findings from the study on TR35 and esophageal cancer, and what do they mean?

The study found that TR35, derived from Xinjiang Bactrian camel milk, inhibits the proliferation of Eca109 esophageal cancer cells and induces apoptosis. In vivo experiments showed that TR35 suppressed the growth of xenografted tumors in nude mice without significant loss in body weight. This is crucial because it suggests that TR35 can fight cancer without causing the debilitating side effects often associated with conventional treatments. These findings highlight TR35's potential as a therapeutic agent.

4

What are the limitations of this research on TR35 and esophageal cancer, and what future steps are planned?

The study is an early-stage investigation. While the results are promising, more research is necessary to fully understand the mechanisms of action of TR35 and its potential for clinical application. Clinical trials will be necessary to confirm the safety and efficacy of TR35 in human patients with esophageal cancer. The findings open up exciting avenues for further research and potential therapeutic development, emphasizing the need for future studies to validate these initial observations.

5

What is the significance of using camel milk, specifically the TR35 fraction, in the treatment of esophageal cancer, and why is it considered innovative?

The use of camel milk, particularly the TR35 fraction, represents an innovative approach to treating esophageal cancer. Esophageal cancer has a low five-year survival rate. Traditional treatments often have significant side effects. TR35 offers a potential alternative derived from a natural source. TR35, extracted from Xinjiang Bactrian camel milk, has demonstrated the ability to inhibit the proliferation of cancer cells and induce apoptosis both in laboratory settings and in living organisms (in vivo). This novel approach challenges conventional treatments, presenting a new direction in cancer therapy by using a component with potential anti-cancer properties from an unexpected source.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.